Pfizer, Arvinas announce global collaboration to develop and commercialize PROTAC protein degrader ARV-471
July 22, 2021 – Arvinas, Inc. and Pfizer Inc. (New York, NY) announced a global collaboration to develop and commercialize ARV-471, an investigational oral PROTAC…